BPC-157 is a synthetic 15-amino-acid peptide supplied as a lyophilized research material. It is commonly evaluated in controlled laboratory settings involving peptide characterization, analytical method development, cell-signaling assays, and preclinical experimental models.
The BPC-157 sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its defined structure allows qualified researchers to examine peptide identity, stability, solubility, degradation, and interactions with selected molecular and cellular systems.
Published preclinical literature has evaluated BPC-157 in cell cultures and nonhuman experimental models involving fibroblast behavior, endothelial signaling, nitric oxide-associated pathways, extracellular-matrix activity, oxidative-stress markers, and other biochemical processes. These areas describe laboratory research contexts only and do not establish safety, efficacy, or an approved application in humans or animals.
Nordsci supplies BPC-157 in 5mg, 10mg, and 15mg vial sizes for qualified laboratory research. Researchers should review the batch-specific Certificate of Analysis before beginning an experiment and independently determine whether the material is suitable for the intended analytical method or research design.
This product is not a drug, medicine, dietary supplement, food, cosmetic, or medical device. It is not intended for human or veterinary use, human or animal consumption, diagnostic procedures, therapeutic applications, compounding, or household use.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
BPC-157 research material can be purchased online from laboratory suppliers that clearly identify the compound as research-use-only material.
When comparing suppliers, qualified purchasers should evaluate whether each vendor provides:
Nordsci supplies BPC-157 exclusively as a laboratory research material. Product availability does not indicate approval for clinical, diagnostic, therapeutic, dietary, cosmetic, or veterinary applications.
BPC-157 product specifications should allow researchers to identify the material and evaluate whether it aligns with their laboratory requirements.
Relevant specifications may include:
The applicable Certificate of Analysis should be reviewed for batch-specific testing methods and results. A general purity statement should not replace examination of the documentation associated with the individual lot.
The price of BPC-157 research material varies according to vial quantity, manufacturing requirements, analytical testing, documentation, packaging, and supplier quality-control procedures.
Researchers should compare products using equivalent unit sizes and specifications. A lower listed price may not represent equivalent material if the products differ in stated quantity, documentation, analytical methods, or supplier controls.
Online pricing for BPC-157 varies substantially between suppliers and vial sizes. The listed price for this Nordsci product begins at $60.00, with the applicable price displayed for each available unit size.
Prices shown by other suppliers may change and should be evaluated alongside the product’s stated quantity, documentation, testing, and research-use restrictions.
Supplier pricing may reflect differences in:
Researchers should evaluate the complete product specification rather than relying solely on the listed price.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
BPC-157, also known as Body Protection Compound-157, is a synthetic pentadecapeptide supplied as a laboratory research material. It contains 15 amino acids and is manufactured through chemical synthesis for controlled analytical and experimental use.
Published research involving BPC-157 has included biochemical assays, cell cultures, and nonhuman experimental systems. Investigated subjects include peptide stability, fibroblast activity, cell migration, endothelial signaling, nitric oxide-associated pathways, extracellular-matrix processes, oxidative-stress markers, and molecular responses under defined laboratory conditions.
These research categories do not establish that BPC-157 is safe or effective for any clinical, consumer, or veterinary purpose. Nordsci BPC-157 is supplied exclusively for controlled laboratory research conducted by qualified professionals.
Shop All PeptidesBPC-157 is a laboratory-synthesized peptide composed of 15 amino acids. Scientific literature describes the sequence as a fragment associated with a larger gastric protein.
Its defined structure makes BPC-157 a subject of laboratory investigation involving:
These are experimental research categories. They should not be interpreted as health claims, approved indications, expected physiological outcomes, or instructions for use.
BPC-157 is a pentadecapeptide with the following reported structural and product characteristics:
| Product | BPC-157 |
|---|---|
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | Approximately 1419.56 g/mol |
| PubChem CID | 108101 |
| Form | Lyophilized research material |
| Source | Chemical synthesis |
| Available Unit Sizes | 5mg, 10mg, or 15mg per vial |
| Testing | Review the batch-specific Certificate of Analysis for applicable identity, purity, and analytical testing information |
| Intended Use | In-vitro laboratory research only |
Researchers should verify product specifications against the label and batch-specific Certificate of Analysis.
Reference: PubChem Compound Summary for BPC-157
Published literature has examined BPC-157 in laboratory and nonhuman experimental systems. The following sections describe general areas of scientific investigation without presenting the compound as a treatment, consumer product, or approved veterinary material.
Laboratory studies have incorporated BPC-157 into experiments involving fibroblast proliferation, migration, cytoskeletal organization, and extracellular-matrix activity.
Fibroblasts are frequently evaluated in laboratory models because of their involvement in collagen production, matrix organization, cell adhesion, and tissue-model development. Experimental methods associated with this research have included cell-culture assays, microscopy, protein analysis, staining procedures, and gene-expression measurements.
Results obtained from these systems are specific to the models, methods, concentrations, controls, and endpoints used. They do not establish safety, efficacy, or expected outcomes in humans or animals.
BPC-157 has been examined in cell-based and nonhuman models involving endothelial-cell behavior and vascular-signaling pathways.
Reported research subjects include:
Findings obtained from cultured cells, embryos, rodents, or other nonhuman systems cannot be treated as clinical evidence. This product is not intended for cardiovascular, circulatory, therapeutic, diagnostic, or other medical applications.
Preclinical studies have incorporated BPC-157 into experimental systems involving tendon-derived fibroblasts and connective-tissue markers.
Methods reported in this area of research include:
These endpoints are used to observe cellular and molecular activity under controlled laboratory conditions. References to connective tissue identify the experimental system and do not indicate an approved application or expected physiological result.
BPC-157 has been examined in nonhuman and cell-based models measuring oxidative-stress-associated markers.
Reported laboratory endpoints include reactive oxygen species, lipid-peroxidation markers, nitric oxide-associated activity, and biochemical responses under defined experimental conditions.
These observations remain limited to their respective models, methodologies, concentrations, controls, and endpoints. They should not be interpreted as evidence of a health benefit or consumer application.
Some published studies have evaluated BPC-157 alongside other compounds in nonhuman toxicology and pharmacology models.
Experimental endpoints have included:
This research does not authorize BPC-157 for use with medications or for any clinical, pharmaceutical, diagnostic, or therapeutic purpose. Nordsci does not provide drug-combination, administration, or clinical-use guidance.
BPC-157 has been included in research involving several nonhuman systems, including rodent, avian, cell-culture, and honeybee models.
Honeybee research has examined gastrointestinal and colony-level endpoints under controlled apiary conditions. These studies represent species-specific experimental observations and do not establish a veterinary application.
Nordsci BPC-157 is not intended for animal use, veterinary practice, feed applications, agriculture, or environmental release.
Future BPC-157 research may further evaluate the compound’s physicochemical characteristics and behavior in controlled laboratory systems.
Potential research categories include:
Research protocols should incorporate suitable controls, validated analytical methods, documented concentrations, predefined endpoints, and institutionally approved handling procedures.
Results from cell cultures and nonhuman models do not establish human relevance, safety, efficacy, or an acceptable route of exposure. Nordsci does not provide dosing, injection, administration, application, consumption, or human-use instructions.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR IN-VITRO LABORATORY RESEARCH. NOT FOR HUMAN OR VETERINARY USE. NOT FOR CONSUMPTION. NOT FOR DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, SUPPLEMENT, COMPOUNDING, OR HOUSEHOLD USE.
This research overview is prepared and maintained by Nordsci for qualified laboratory researchers evaluating BPC-157 as an analytical research material.
The information is educational and describes published laboratory and preclinical research categories. It does not constitute medical, veterinary, pharmaceutical, compounding, diagnostic, or laboratory-safety advice.
Researchers are responsible for reviewing the original publications, verifying product specifications, examining batch-specific documentation, and determining whether the material is appropriate for their institutionally approved research.
Predrag Sikiric is an academic researcher whose name appears in multiple publications concerning BPC-157 and related experimental models. He has been affiliated with the University of Zagreb.
Predrag Sikiric is identified solely in connection with authorship of cited scientific literature. This reference does not indicate an endorsement, recommendation, commercial relationship, or affiliation between the researcher and Nordsci.
No scientist, author, institution, publisher, or journal cited on this page should be understood as endorsing the purchase, sale, or use of this product.
Citation titles are reproduced for bibliographic identification and do not represent product claims, approved uses, or endorsements by Nordsci.
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
Products offered by Nordsci are furnished exclusively for in-vitro laboratory research. In-vitro research is conducted outside a living organism. These products are not drugs, medicines, foods, dietary supplements, cosmetics, or medical devices and have not been approved by the FDA for clinical, diagnostic, therapeutic, veterinary, or consumer use.
Human or animal consumption, administration, application, compounding, and bodily introduction are strictly prohibited.
